Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2017-03-13
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study aims to evaluate, if femoral nerve blockade can significantly decrease pain during the procedure without prolonging the stay in the hospital.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Hypnoanalgesia in Surgical and Endovenous Treatment of Varicosis
NCT03601572
Delayed or Immediate Local Treatment of Veins
NCT03340246
Compression And Functional Ability After Endovenous Varicose Vein Treatment
NCT03613376
Mechanochemical Ablation vs Thermal Ablation
NCT03722134
Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein
NCT05001776
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thanks to technical advancement open surgery has been replaced By endovenous means. Currently endovenous thermal ablation is a golden standard for main trunk disease. For efficient patient and procedure flow majority of thermal ablations are performed at the outpatient setting. However, if patient is suffering from significant varicose veins, treating both legs, may be unpleasant to the patient.
Aim of the study is, whether addition of femoral nerve blockade to the tumescent anesthesia can decrease pain during the procedure without prolonging the stay in the hospital.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The current standard anesthesia
Standard treatment during procedure
The current standard treatment
Tumescent anesthesia.
Femoral nerve blockade
Femoral nerve blockade added to the standard treatment.
Femoral nerve blockade
The femoral nerve blockade with lidocain is combined to the tumescent anesthesia.
The current standard treatment
Tumescent anesthesia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Femoral nerve blockade
The femoral nerve blockade with lidocain is combined to the tumescent anesthesia.
The current standard treatment
Tumescent anesthesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* CEAP class 2-4
Exclusion Criteria
* Pregnancy
* CEAP 5-6
* BMI\>40
* Allergy to lidocain
20 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maarit Venermo
Professor in Vascular Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anders Alback, MD,PhD
Role: STUDY_CHAIR
Head of Depratment
Karoliina H Halmesmaki, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Head of Venous Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki University Hospital, Finland
Helsinki, Uusimaa, Finland
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hurmerinta-Kurkijarvi O, Weselius EM, Halmesmaki K, Vikatmaa P, Vikatmaa L, Venermo M. Femoral nerve blockade during endovenous laser ablation of great saphenous vein decreases pain but does not affect the use of opioids during the procedure. J Vasc Surg Venous Lymphat Disord. 2023 Sep;11(5):921-927. doi: 10.1016/j.jvsv.2023.04.007. Epub 2023 May 2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FEMINE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.